Sr. Director - Consumer Media at Eli Lilly and Company

Indianapolis, Indiana, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Healthcare, PharmaceuticalsIndustries

Requirements

Seasoned media strategist capable of influencing at the highest levels
Ability to deliver financial stewardship with rigor and transparency
Experience building talent and organizational capability in consumer media
Expertise in balancing enterprise-wide priorities with brand-level needs
Strong influential communication skills to translate complexity into clear narratives
Disciplined decision-making for accountability and maximizing enterprise value
Curiosity and innovation to anticipate shifts in consumers, culture, technology, and media
Leadership experience overseeing teams of 3–4 and key external agency partnerships

Responsibilities

Balance enterprise-wide priorities with brand-level needs, setting a cohesive vision for long-term growth and near-term performance
Translate complexity into clear, compelling narratives to build trust and alignment with executives and teams
Make disciplined, transparent decisions that maximize enterprise value and investment impact
Anticipate shifts in consumers, culture, and technology to proactively shape future-ready strategies
Elevate people and partnerships through mentorship, empowerment, and accountability
Set the vision and framework for consumer media strategy across brands, ensuring alignment to enterprise priorities and long-term growth
Define enterprise media objectives, channel principles, and measurement standards to drive consistency, maximize business impact, and push toward innovation
Serve as a trusted advisor to senior executives on media and marketing investment strategy
Translate complex data and insights into clear recommendations that inform enterprise decision-making
Build organizational alignment around media’s role in delivering customer-centric experiences and driving business performance
Oversee key external partnerships, ensuring agency accountability, evolving capabilities, and strategic value creation
Monitor shifts in the market, consumer behavior, and media innovation, proactively advising on opportunities and risks

Skills

Media Strategy

Consumer Media

Agency Partnerships

Strategic Planning

Team Leadership

Data-Driven Insights

Media Objectives

Channel Strategy

Investment Frameworks

Governance

Eli Lilly and Company

Develops and delivers prescription medicines globally

About Eli Lilly and Company

Eli Lilly and Company is a global pharmaceutical company that focuses on discovering, developing, and delivering medicines to improve health. The company has a long history of scientific achievements, including the creation of insulin, the first life-saving treatment for diabetes. Lilly's operations involve extensive research and development to create new medications and enhance existing ones, ensuring they are safe and effective. Their products are primarily prescription medicines sold to healthcare providers for various medical conditions, including diabetes, cancer, and pain management. What sets Lilly apart from its competitors is its strong commitment to ethical practices and the protection of its products from counterfeiting. The company's goal is to enhance lives through innovative medical solutions while maintaining high standards of quality and ethics.

Indianapolis, IndianaHeadquarters

1876Year Founded

$1,180.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Competition from Novo Nordisk's Ozempic may impact tirzepatide's market share.

Potential construction delays in Indiana could affect GLP-1 drug production timelines.

Regulatory challenges may hinder Kisunla's expansion in new Alzheimer's markets.

Differentiation

Eli Lilly's rich history includes the first life-saving insulin treatment.

Lilly's strategic partnerships enhance its position in neurodegenerative disease treatments.

FDA approval of Zepbound opens new therapeutic markets for sleep disorder treatments.

Upsides

Lilly's $9 billion complex in Indiana boosts GLP-1 drug production capacity.

Kisunla's approval in China expands Lilly's Alzheimer's treatment market in Asia.

Collaboration with EVA Pharma enhances Lilly's reputation as socially responsible.

Land your dream remote job 3x faster with AI

Try Jobo Free